The close relationship between IDO2 and CD4 + T cell infiltration in the MTC microenvironment, together with its potential prognostic implications, could open the way for the assessment of a possible therapeutic target with IDO2 selective inhibitors, both by discovering new pathogenic mechanisms and by exploring new pharmacological agents for MTC. Here, CD4 is linked to medullary thyroid gland carcinoma.